XML 95 R37.htm IDEA: XBRL DOCUMENT v3.20.1
CAPITAL STOCK (Tables)
3 Months Ended
Mar. 31, 2020
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of weighted average valuation assumptions
The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions for options granted in the three months ended March 31, 2020 and 2019.
 
Three Months Ended March 31,
 
2020
 
2019
Risk-free interest rate
0.72%
 
2.45%
Expected lives
4.5 years
 
4.7 years
Expected volatility
39%
 
39%
Expected dividend yield
0%
 
0%
Schedule of stock options plans
The following table summarizes restricted stock transactions for the three months ended March 31, 2020:
 
RSAs
 
Weighted-Average Grant Date Fair Value Per Award
Non-vested as of December 31, 2019
335,667

 
$
74.29

     Granted
250

 
86.57

     Vested
(16,894
)
 
48.77

     Forfeited
(46,000
)
 
64.59

Non-vested as of March 31, 2020
273,023

 
$
77.44

A summary of our stock option plans is as follows:
 
Three Months Ended March 31,
 
Year Ended December 31,
 
2020
 
2019
 
Options
 
Weighted Average Exercise Price
 
 
 Options
 
Weighted Average Exercise Price
Outstanding at beginning of period
536,315

 
$
54.855

 
620,553

 
$
40.741

Granted at market
250

 
$
95.660

 
88,200

 
$
84.234

Forfeited
(35,641
)
 
$
70.546

 
(1,353
)
 
$
98.660

Expired
(1,051
)
 
$
98.660

 
(716
)
 
$
98.660

Exercised
(10,483
)
 
$
8.779

 
(170,369
)
 
$
18.125

Outstanding at end of period
489,390

 
$
54.626

 
536,315

 
$
54.855

Exercisable at end of period
339,845

 
$
41.893

 
315,964

 
$
37.644

Schedule of shares authorized under stock options plans by exercise price
The following table summarizes information about stock options outstanding and exercisable at March 31, 2020:
 
 
Options Outstanding
 
Options Exercisable
Exercise Prices
 
Number of
Options
Outstanding
at
March 31, 2020
 
Weighted
Average
Remaining
Contractual
Life in Years
 
Weighted
Average
Exercise
Price
 
Number of
Options
Exercisable
at
March 31, 2020
 
Weighted
Average
Exercise
Price
4.96-7.36
 
78,733

 
2.72
 
$
7.022

 
78,733

 
$
7.022

7.37-62.50
 
123,943

 
3.72
 
$
26.115

 
123,838

 
$
26.088

62.51-69.77
 
101,668

 
6.90
 
$
69.770

 
71,669

 
$
69.770

69.78-72.85
 
84,391

 
6.67
 
$
72.237

 
41,779

 
$
72.850

72.86-108.25
 
100,655

 
8.77
 
$
96.909

 
23,826

 
$
101.137

4.96-108.25
 
489,390

 
5.77
 
$
54.626

 
339,845

 
$
41.893

Schedule of pricing models
The weighted average assumptions used for the periods presented were as follows:
 
Three Months Ended March 31,
 
2020
 
2019
Risk-free interest rate
1.34%
 
2.35%
Expected lives
1.1 years
 
1.1 years
Expected volatility
44%
 
40%
Expected dividend yield
0%
 
0%